NT Neumora Therapeutics, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Neumora Therapeutics, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €284.7m. The latest transaction was reported on 21 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Aurora Daljit Singh. Every trade is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Neumora Therapeutics, Inc. Buy (bullish), based on 7 analysts. Average price target: US$6.14.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 August 2026
All Executives94 Thresholds0 Prospectus0 Other0
Declarations 94 total
● Officer · Executives · 21 Aug 2026
41,608 shares @ US$1.5954 Common Stock SEC144:0001964306-26-000408
◇ See Remarks · Executives · 20 Aug 2026
67,741 shares @ US$0.72 0.017% mcap 2.4% of flow Common Stock SEC:0001610717-26-000385:0
▼ See Remarks · Executives · 20 Aug 2026
67,741 shares @ US$1.5144 0.036% mcap 5.1% of flow Common Stock SEC:0001610717-26-000385:1
◇ See Remarks · Executives · 20 Aug 2026
21,685 shares @ US$0.72 0.0055% mcap 0.8% of flow Common Stock SEC:0001610717-26-000385:2
◇ See Remarks · Executives · 20 Aug 2026
45,026 shares @ US$0.72 0.011% mcap 1.6% of flow Common Stock SEC:0001610717-26-000385:3
▼ See Remarks · Executives · 20 Aug 2026
66,711 shares @ US$1.514 0.036% mcap 5.1% of flow Common Stock SEC:0001610717-26-000385:4
◇ See Remarks · Executives · 21 Aug 2026
20,553 shares @ US$0.72 0.0052% mcap 0.7% of flow Common Stock SEC:0001610717-26-000385:5
▼ See Remarks · Executives · 21 Aug 2026
20,553 shares @ US$1.5949 0.012% mcap 1.6% of flow Common Stock SEC:0001610717-26-000385:6
◇ See Remarks · Executives · 21 Aug 2026
21,055 shares @ US$0.72 0.0053% mcap 0.8% of flow Common Stock SEC:0001610717-26-000385:7
▼ See Remarks · Executives · 21 Aug 2026
21,055 shares @ US$1.5958 0.012% mcap 1.7% of flow Common Stock SEC:0001610717-26-000385:8
● Officer · Executives · 20 Aug 2026
134,452 shares @ US$1.5142 0.072% mcap 12.7% of flow Common Stock SEC144:0001964306-26-000403
● Officer · Executives · 19 Aug 2026
61,918 shares @ US$1.646 0.036% mcap 7.4% of flow Common Stock SEC144:0001964306-26-000401
◇ See Remarks · Executives · 17 Aug 2026
40,890 shares @ US$0.72 0.010% mcap 2.3% of flow Common Stock SEC:0001610717-26-000362:0
◇ See Remarks · Executives · 17 Aug 2026
15,355 shares @ US$0.72 0.0039% mcap 0.9% of flow Common Stock SEC:0001610717-26-000362:1
◇ See Remarks · Executives · 17 Aug 2026
1,424 shares @ US$0.72 0.0004% mcap 0.1% of flow Common Stock SEC:0001610717-26-000362:2
◇ See Remarks · Executives · 17 Aug 2026
1 shares @ US$0.72 0.0000% mcap 0.0% of flow Common Stock SEC:0001610717-26-000362:3
▼ See Remarks · Executives · 17 Aug 2026
57,670 shares @ US$1.5055 0.031% mcap 6.8% of flow Common Stock SEC:0001610717-26-000362:4
▼ See Remarks · Executives · 17 Aug 2026
34,020 shares @ US$1.4853 0.018% mcap 3.9% of flow Common Stock SEC:0001610717-26-000362:5
◇ See Remarks · Executives · 17 Aug 2026
25,279 shares @ US$0.72 0.0064% mcap 1.4% of flow Common Stock SEC:0001610717-26-000362:6
◇ See Remarks · Executives · 17 Aug 2026
29,737 shares @ US$0.72 0.0076% mcap 1.7% of flow Common Stock SEC:0001610717-26-000362:7
▼ See Remarks · Executives · 17 Aug 2026
55,016 shares @ US$1.5047 0.029% mcap 6.5% of flow Common Stock SEC:0001610717-26-000362:8
◇ See Remarks · Executives · 18 Aug 2026
34,162 shares @ US$0.72 0.0087% mcap 1.9% of flow Common Stock SEC:0001610717-26-000362:9
▼ See Remarks · Executives · 18 Aug 2026
34,162 shares @ US$1.5847 0.019% mcap 4.2% of flow Common Stock SEC:0001610717-26-000362:10
◇ See Remarks · Executives · 18 Aug 2026
34,987 shares @ US$0.72 0.0089% mcap 2.0% of flow Common Stock SEC:0001610717-26-000362:11
▼ See Remarks · Executives · 18 Aug 2026
34,987 shares @ US$1.5859 0.020% mcap 4.3% of flow Common Stock SEC:0001610717-26-000362:12
25 of 94 declarations
Load more (69 remaining) 关于 Neumora Therapeutics, Inc. Neumora Therapeutics, Inc. 是一家生物制药公司，专注于开发神经系统疾病的创新疗法。它利用基于数据科学的方法来识别新疗法。